Legal & Regulatory

The end of SSFFCs?

Bills passes House with broad bipartisan support; Senate approval likely

Upcoming trial could explore the intricacies of ‘alternative fulfillment’ via specialty pharmacies

Working out these details points to how full compliance will look in 2023

Compliance with the Physicians’ Sunshine Act has moved quickly into obtaining business value

NABP tracks rogue online pharmacies; WHO codifies international testing standards for SSFFCs

US courts fail to clarify when pricing may violate antitrust laws

More evidence that drug abusers are at risk from counterfeiters

CIS by Deloitte seeks to provide a comprehensive service for revenue management

‘Operation Black Market Meds’ involved New York State, Florida and federal investigators

Painkiller addicts buy street drugs that simulate well-known pharma brands

AAPA is positioning itself to provide alternative certification

WDSrx expands controlled substances storage

The growing compliance requirements for distribution call for 
a streamlined approach

New guidance restricts some compounding to other than “essentially copies” of approved products

check on your doc, a company or a form of compensation

Pharma sales practices get raked over again—to what end?

Case falls apart as a 'skeptical' judge calls the company 'factually innocent'

Feds contend that FedEx knowingly performed illegal drug deliveries

rfXcel’s Traceability Platform becomes part of Verizon’s ThingSpace

New physician’s form is supposed to reduce the complexity of obtaining investigational drugs

Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) calls for better industry-government coordination